跳至主要内容
临床试验/NCT01895426
NCT01895426已完成不适用

Clinical Follow-up of the ArcadiusXP L Stand Alone Intervertebral Body Fusion Device

Aesculap AG2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Aesculap AG
入组人数
32
试验地点
2
主要终点
ODI (2y) - ODI(preop)

研究概览

简要总结

The purpose of this study is to collect clinical and radiological mid-term (2 years) data on the ArcadiusXP L® lumbar stand-alone cage in a post-market clinical follow-up study (PMCF) limited to 32 patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • all indications as given by the instructions for use
  • Patients with persisting lumbosacral and pseudo-radicular pain scheduled for monosegmental lumbar interbody fusion from L4 to S1
  • Age 18 - 60
  • at least 6 months of unsuccessful treatment including conservative measures
  • Non-sequestrated and subligamentous prolapse

排除标准

  • all contraindications, which are listed in the instructions for use.
  • existing pregnancy, planned or occurring during study period
  • patients with a higher degree of segmental degeneration in other than the segment to be operated
  • body- mass-index (BMI) > 30
  • Systemic or local infection
  • Increased risk of osteoporosis according to assessment by the SCORE evaluation
  • Bone metabolism disorders
  • Chemotherapy or radiotherapy (ongoing or planned)
  • Participation in another clinical trial
  • Scheduled for spinal litigation
  • Other serious conditions that hinder the participation in the study
  • Nanogel® filling of the cage, prior to implantation was not done

结局指标

主要结局

ODI (2y) - ODI(preop)

时间窗: 2 years

Difference between Oswestry Disability Index (ODI) at 2 years and preoperative ODI

次要结局

  • Concomitant pain medication(2 years)
  • Overall success(2 years)
  • Pain (back and leg)(2 years)
  • Adverse events(2 years)
  • Fusion/arthrodesis status, and further radiological documentation of operated and adjacent levels(2 years)
  • Patient satisfaction(2 years)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验